• Western blot analysis of various lysates using MOXD1 Rabbit polyclonal antibody (STJ116250) at 1:3000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. Lysates/proteins: 25 Mu g per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 1s.

Anti-MOXD1 antibody (390-590) (STJ116250)

SKU:
STJ116250

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-MOXD1 (390-590) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:500-1:2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: MOXD1
Gene ID: 26002
Uniprot ID: MOXD1_HUMAN
Immunogen Region: 390-590
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 390-590 of human MOXD1 (NP_056344.2).
Immunogen Sequence: AHLAGRGIRLRHFRKGKEMK LLAYDDDFDFNFQEFQYLKE EQTILPGDNLITECRYNTKD RAEMTWGGLSTRSEMCLSYL LYYPRINLTRCASIPDIMEQ LQFIGVKEIYRPVTTWPFII KSPKQYKNLSFMDAMNKFKW TKKEGLSFNKLVLSLPVNVR CSKTDNAEWSIQGMTALPPD IERPYKAEPLVCGTSSSSSL H
Tissue Specificity Highly expressed in lung, kidney, brain and spinal cord.
Post Translational Modifications N-glycosylated.
Protein Name Dbh-Like Monooxygenase Protein 1
Monooxygenase X
Cellular Localisation Endoplasmic Reticulum Membrane
Single-Pass Type I Membrane Protein
Alternative Antibody Names Anti-Dbh-Like Monooxygenase Protein 1 antibody
Anti-Monooxygenase X antibody
Anti-MOXD1 antibody
Anti-MOX antibody
Anti-UNQ2493 antibody
Anti-PRO5780 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance